Aegon (AEG) Q2 2026 earnings review
All-in on the US: Strategic Pivot Shadows Mixed Financials
Aegon's 1H 2026 results reflect a company in massive transition. The headline story is strategic: Aegon is finalizing its exit from Europe by selling Aegon UK for £2.0 billion and officially moving its headquarters to New York City. Operationally, the core business showed strength with Operating Result accelerating 9% to €804 million. However, this growth didn't reach the bottom line. Net Income remained stable at €608 million, held back by a €294 million hit from adverse actuarial assumption changes in the legacy US book. Despite the flat net profit, management is returning heavy capital, hiking the interim dividend by 11% and expanding the share buyback by €150 million.
🐂 Bull Case
Transamerica Individual Life sales surged 54%, driven by a new instant decision digital platform. The World Financial Group (WFG) agent count broke 100,000, driving 12% growth in annuity sales.
Asset Management was the standout segment, with operating results accelerating 44% to €150 million, fueled by strong Global Platforms margin expansion (15.5% to 20.2%) and strategic partnership inflows.
🐻 Bear Case
The annual assumption review resulted in a €294 million charge. Policyholders are holding onto older Universal Life policies longer than expected and lapsing Traditional Life less than expected, proving the legacy book remains a drag.
The Group Solvency ratio reversed sharply from 184% to 169%, driven by debt eligibility changes and shareholder returns. Meanwhile, Retirement Plans hemorrhaged $5.1 billion in net outflows.
⚖️ Verdict: ⚪
Neutral. The underlying growth in US distribution and Asset Management is highly encouraging, and the UK sale perfectly aligns the portfolio. However, massive actuarial true-ups and a plunging solvency ratio show the transition to a clean US entity is still messy.
Key Themes
The Great US Migration and UK Exit
Aegon is executing its 2025 Capital Markets Day ambition with ruthless speed. The company sold Aegon UK to Standard Life for £2.0 billion (comprising £1.25B in Standard Life shares and £750M in cash). Combined with the selection of New York City as the future headquarters and the targeting of October 2026 for the redomiciliation EGM, Aegon is effectively becoming a pure-play US/Americas insurer. $137 million has been spent on US GAAP implementation and relocation so far.
WFG Expansion Drives Transamerica Growth
Transamerica's focus on the middle and mass-affluent markets is accelerating. The World Financial Group (WFG) network added roughly 10,000 agents YoY to cross the 100,000 licensed agent mark. This directly translated into a 54% YoY spike in Individual Life new sales and a 12% increase in total annuity sales. Transamerica's market share within WFG US Life expanded from 66% to 70%.
Actuarial Assumptions Bite Back
A massive red flag surfaced in Other Charges, which hit -€160 million. This was driven primarily by a €294 million charge from the annual model and assumption review in the Americas. The issue: policyholder behavior. Customers are keeping older, onerous Universal Life policies active longer than projected, and failing to lapse Traditional Life policies. When policyholders don't act as the models predict, the economic value of the legacy book gets crushed.
Group Solvency Ratio Reversing
The Group Solvency ratio dropped 15 percentage points in six months, falling from 184% to 169%. This deceleration was heavily driven by the loss of capital eligibility for Perpetual Capital Subordinated Bonds (-9%), aggressive share buybacks, and the interim dividend (-10%), further compounded by the negative impact of the actuarial assumption updates. While 169% remains above operating levels, the rapid compression limits future flexibility.
Retirement Plans Experiencing Heavy Outflows
Transamerica's Savings & Investments segment is showing significant friction. Net deposits for Retirement Plans swung from a $2.1 billion inflow in 25H1 to a $5.1 billion outflow in 26H1. While $3.0 billion of this was a one-time contract termination due to a merger, the remaining $2.1 billion bleed was caused by increased participant withdrawals capitalizing on higher account balances. Gross deposits also fell 7% YoY.
Asset Management Profitability Expanding
Asset Management operating results are accelerating, jumping 44% YoY to €150 million. Even excluding the transfer of Transamerica Asset Management (TAM) to this segment, organic operating results grew 25%. Global Platforms benefited from ongoing expense management and favorable markets, pushing the operating margin up nearly 500 basis points to 20.2%.
Other KPIs
Decelerating. Insurance revenue fell from €4.56 billion in 25H1, reflecting the run-off of the Financial Assets legacy blocks and adjustments in the International portfolio, despite strong new sales in the US Protection Solutions segment.
Declined from €6.28 billion at year-end 2025. However, this is artificially depressed by the classification of Aegon UK as held for sale. Adjusting for the €1.46 billion CSM transferred to disposal groups, the underlying CSM actually grew, aided by strong new business generation in US Protection Solutions that finally outpaced the release of CSM.
Stable. Excluding the historical contributions from Aegon UK (which are now treated as divestitures), underlying Free Cash Flow was flat YoY. Capital generation was sufficient to support the newly expanded €350 million share buyback and 11% dividend hike.
Guidance
Management expects to grow the operating result by ~5% per annum starting from a pro forma 2025 run-rate baseline of €1.3 - €1.5 billion (which removes Aegon UK contribution and assumes a 1.20 EUR/USD exchange rate). Based on the 26H1 result of €804 million, the company is currently pacing well ahead of this baseline.
Targeting ~5% annual growth off a pro forma 2025 run-rate of €0.68 billion. This ambition explicitly excludes any future remittances from Aegon UK or dividends received from their new stake in Standard Life.
Management reaffirmed its ambition to grow the dividend per share in excess of 5% per annum. The 11% hike in the 26H1 interim dividend (to €0.21) signals strong confidence in achieving this target.
Key Questions
Legacy Assumption Drag
The €294 million hit from Universal and Traditional Life policyholder behavior is significant. What gives you confidence that this year's assumption updates have fully captured the persistency risks, and are we completely ring-fenced from further true-ups in 2027?
Solvency Buffer Floor
Group Solvency fell 15 points to 169%. With the upcoming acceleration of Bermuda solvency framework reporting in late 2026, and further capital returns planned, what is your absolute minimum internal floor for the Solvency ratio before buybacks are paused?
Retirement Plan Attrition
Excluding the $3.0 billion merger-related termination, Retirement Plans still saw $2.1 billion in net outflows due to higher participant withdrawals. Is this purely macro-driven behavior, or are you seeing competitive pressure on fees and offerings?
Standard Life Stake Strategy
You will receive a 15.3% stake in Standard Life as part of the UK sale. Do you view this as a long-term strategic holding, or is it a liquid asset designated for eventual monetization to fund further US expansion?